|
FDA approves Paragonix organ-donation device for commercial use
San Antonio Business Journal The Food and Drug Administration has approved Paragonix Technologies Inc.’s heart-transportation system for market. The Paragonix Sherpa Pak Cardiac Transport System can be used to preserve hearts during transportation and eventual transplantation … |
John Kerr, Tony-Winner for 'Tea & Sympathy,' Dies – ABC News
|
John Kerr, Tony-Winner for ‘Tea & Sympathy,’ Dies
ABC News Kerr died Saturday of heart failure at Huntington Hospital in Pasadena, his son Michael said. He was perhaps best known for playing a sensitive prep school student who is bullied for being a suspected homosexual in Elia Kazan’s 1953 Broadway production … |
Gains from mine will go to foreigners – Wisconsin Dells Events
Gains from mine will go to foreignersWisconsin Dells EventsIn the Minnesota Iron range, which produces 70 percent of the taconite iron ore in the country, there is an alarming number of mesothelioma and lung cancer cases among the iron workers. … The…
'Calcium sponge' to tackle diastolic heart failure – Pakistan Observer
|
‘Calcium sponge’ to tackle diastolic heart failure
Pakistan Observer Wednesday, February 13, 2013 – RESEARCHERS have used molecular genetic engineering to optimize heart performance in models of diastolic heart failure by creating an optimized protein that can aid in high-speed relaxation similar to fast twitching … |
11 for Mission Heartbeat 2013 – Demerara Waves
11 for Mission Heartbeat 2013Demerara WavesEleven patients from Guyana are due to leave for India where they will undergo medical treatment for heart, brain, liver, kidney and eye ailments, according to the Three Rivers Foundation. Foundation President…
Synthetic Marijuana Linked to Acute Kidney Injury – Medscape
MedscapeSynthetic Marijuana Linked to Acute Kidney InjuryMedscapeAcute kidney injury (AKI) has been added to the growing list of deleterious health effects that include psychosis, birth defects, behavioral changes, and acute coronary syndrome associate…
TG Therapeutics, Inc. Opens Expansion Cohorts in Its Phase I/II Trial of TG … – PharmaLive (press release) (subscription)
TG Therapeutics, Inc. Opens Expansion Cohorts in Its Phase I/II Trial of TG …PharmaLive (press release) (subscription)Coupled with the clinical activity seen in both rituximab relapsed and refractory patients across the dose levels tested thus far, w…
TEMECULA: An entertaining look at organ donation – Press-Enterprise
 Press-Enterprise |
TEMECULA: An entertaining look at organ donation
Press-Enterprise Not only is he determined to sway every resident in the city of Temecula — and beyond — to become a registered organ donor, he’s doing it through a series of eye-opening, comedic, yet heart-warming monthly shows at The Merc in Old Town Temecula … |
How Safe Is Abbvie's Dividend? – Seeking Alpha
|
How Safe Is Abbvie’s Dividend?
Seeking Alpha Daclizumab, a next generation biologic, developed with Biogen for multiple sclerosis. Results from the first of two pivotal trials demonstrated strong efficacy in reducing relapse rates and disability performance. The second pivotal trial is fully … |
Boston Scientific launches Promus Premier stent in Europe – Mass Device
|
Boston Scientific launches Promus Premier stent in Europe
Mass Device based medical device company touts the device as the sole entrant in the DES market to feature a platinum-chromium chassis, an everolimus coating and “an enhanced stent delivery system,” according to a press release. “The Promus Premier stent system is … |